about
Disturbed spermatogenesis associated with thickened lamina propria of seminiferous tubules is not caused by dedifferentiation of myofibroblasts.Macitentan for the treatment of pulmonary arterial hypertension.The α and Δ isoforms of CREB1 are required to maintain normal pulmonary vascular resistance.Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injuryMegakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1.X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.Endothelin-1 directs airway remodeling and hyper-reactivity in a murine asthma model.Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.Circulating biomarkers of interstitial lung disease in systemic sclerosis.Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.New anti-inflammatory targets for chronic obstructive pulmonary disease.The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.Association between ECE1 gene polymorphisms and risk of intracerebral haemorrhage.Endothelin-converting enzyme-1 gene ablation attenuates pulmonary fibrosis via CGRP-cAMP/EPAC1 pathway.Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction.Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphysema and by severe pulmonary hypertension: clinical, functional, and biomolecular findings.
P2860
Q33863416-222411E8-A4A6-4BD0-B394-70CD95A25AEDQ34610092-AA4D3D70-28C6-422C-B297-B0E17D479FE6Q35069403-9E38217D-8E5D-435B-B35C-848213709625Q35621434-550EE886-E2E8-49BA-B501-524AD46B193CQ36595381-9155A364-4E01-486F-ABC2-9476C3AB2BC2Q36963259-4FABC8E6-8C61-412C-B06D-5E085FC5FB9AQ37056479-193EC144-C714-4AE9-ABD0-76D86FB0E686Q37712377-D19EDAE2-DE69-42CA-AA5B-BE3E4242DF1BQ37890199-556E446F-90AA-46DD-A711-58BB6B584556Q38044387-E432BE7B-CABF-435B-B626-825DF3EF7793Q38100470-76733D94-B62E-4F2A-BD64-34B4A9B1138AQ38131512-30F0F44A-B2C4-46A6-8066-D7CA4835A59CQ38290539-7D03CAE2-51B4-494D-A71C-89E127EE1D44Q39995050-17FF6B48-8E8F-4D21-A016-40F9600CF83EQ42144426-F02DFD3A-2891-44F8-9D96-D296C55EA782Q42340221-77D24C7C-A781-41ED-B0F6-C2E819D81C38Q43857708-CE298D48-73A4-4D04-B266-523EA7520819Q47578804-6C869FC1-DA86-4FEF-AF40-C807DACD4E82Q50448734-D8F280AF-C173-4BC2-A751-588A19B6A43CQ51054678-CF794784-BE60-4A64-898F-9A6E3FC05CE0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelin in pulmonary fibrosis.
@en
Endothelin in pulmonary fibrosis.
@nl
type
label
Endothelin in pulmonary fibrosis.
@en
Endothelin in pulmonary fibrosis.
@nl
prefLabel
Endothelin in pulmonary fibrosis.
@en
Endothelin in pulmonary fibrosis.
@nl
P2093
P2860
P356
P1476
Endothelin in pulmonary fibrosis.
@en
P2093
Carmen Fonseca
David Abraham
Elisabetta A Renzoni
P2860
P356
10.1165/RCMB.2009-0388TR
P577
2010-05-06T00:00:00Z